Outcome of half-dose photodynamic therapy in chronic central serous chorioretinopathy with fovea-involving atrophy

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1435-702X
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Outcome of half-dose photodynamic therapy in chronic central serous chorioretinopathy with fovea-involving atrophy ; day:29 ; month:10 ; year:2020 ; pages:1-6
Graefe's archive for clinical and experimental ophthalmology ; (29.10.2020), 1-6

Urheber
Rijssen, Thomas J. van
Dijk, Elon H. C. van
Scholz, Paula
MacLaren, Robert E.
Fauser, Sascha
Downes, Susan M.
Hoyng, Carel B.
Boon, Camiel J. F.
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1007/s00417-020-04959-3
URN
urn:nbn:de:101:1-2020121312232271052767
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:26 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Rijssen, Thomas J. van
  • Dijk, Elon H. C. van
  • Scholz, Paula
  • MacLaren, Robert E.
  • Fauser, Sascha
  • Downes, Susan M.
  • Hoyng, Carel B.
  • Boon, Camiel J. F.
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Real world outcomes of photodynamic therapy for chronic central serous chorioretinopathy

Real world outcomes of photodynamic therapy for chronic central serous chorioretinopathy

No-Dose Photodynamic Therapy Against Half-Dose Photodynamic Therapy for Treatment of Central Serous Chorioretinopathy

No-Dose Photodynamic Therapy Against Half-Dose Photodynamic Therapy for Treatment of Central Serous Chorioretinopathy

Fundus Autofluorescence after Half-Dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy

Fundus Autofluorescence after Half-Dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy

Influence of vortex vein engorgement for photodynamic therapy in central serous chorioretinopathy

Influence of vortex vein engorgement for photodynamic therapy in central serous chorioretinopathy

Aniseikonia after reduced-fluence photodynamic therapy in patients with central serous chorioretinopathy

Aniseikonia after reduced-fluence photodynamic therapy in patients with central serous chorioretinopathy

Single-session bilateral reduced-settings photodynamic therapy for bilateral chronic central serous chorioretinopathy

Single-session bilateral reduced-settings photodynamic therapy for bilateral chronic central serous chorioretinopathy

Photodynamic therapy in chronic central serous chorioretinopathy with subretinal fluid outside the fovea

Photodynamic therapy in chronic central serous chorioretinopathy with subretinal fluid outside the fovea

Predictive risk scores for visual prognosis after photodynamic therapy for central serous chorioretinopathy

Predictive risk scores for visual prognosis after photodynamic therapy for central serous chorioretinopathy

Brachytherapy for Central Serous Chorioretinopathy

Brachytherapy for Central Serous Chorioretinopathy

Extensive reduction in choroidal thickness after photodynamic therapy in eyes with central serous chorioretinopathy

Extensive reduction in choroidal thickness after photodynamic therapy in eyes with central serous chorioretinopathy

Subthreshold micropulse laser photocoagulation versus half-dose photodynamic therapy for acute central serous chorioretinopathy

Subthreshold micropulse laser photocoagulation versus half-dose photodynamic therapy for acute central serous chorioretinopathy

Changes in macular sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy

Changes in macular sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy

Verbundene Objekte